ACTEBR Injectables

Minimally invasive injectable bone graft hydrogel

Injectable Hydrogel Patent Filed Minimally Invasive

ACTEBR Bone Fillers Injectable is a minimally invasive hydrogel injection designed for targeted bone regeneration in periodontal and craniofacial applications. It provides high moisture retention, strong cell attachment, proliferation, and anti-inflammatory properties.

ACTEBR Injectables

Description

ACTEBR Bone Fillers Injectable is a minimally invasive hydrogel injection designed for targeted bone regeneration in periodontal and craniofacial applications. It provides high moisture retention, strong cell attachment, proliferation, and anti-inflammatory properties.

Available Sizes
  • Target Price 15,000 PKR / cc
  • Imported Alternatives 100 USD / cc

Advanced Injectable Applications


Alveolar Bone substitute

Fills small bone voids around dental roots without major surgery.

Infrabony Defects

Injectable filling of vertical bone pockets caused by periodontitis.

Gingival Recession

Scaffold support under gums to treat severe recession voids.

Furcation Defects

Targeted delivery of bone-regenerating gel at root division points.

Guided Tissue Reg.

Minimally invasive GTR hydrogel barrier.

Maxillofacial Voids

Fills small craniofacial voids and osteotomy joints.

Technology Status & Commercialization

Status: Patent filed. Clinical trials and Class III DRAP registration required for commercial medical launch.

Business Potential

No Local Maker

No local manufacturer exists, creating a monopoly potential.

Premium Price Point

Target price of PKR 15,000 per cc provides excellent profitability.

Patient Preference

Minimally invasive injection cuts hospital stay and surgery recovery times.

Injectable Hydrogel Carrier Excellent Cell Proliferation Controlled Drug/Ion Release

Principal Investigator

Prof. Dr. Asma Tufail Shah

Tenured Professor
Head of Dental Group

IRCBM - CUI Lahore Campus

drasmashah@cuilahore.edu.pk

Research Group